Home /Research /30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675)
SURGICAL

30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675)

Travis J. Haller, Xueqian Yin, Thomas J. O’Byrne, Eric J. Moore, D.J. Ma, K.P. Price, Samir H. Patel, M.L. Hinni, M.A. Neben-Wittich, L.A. McGee, Daniel L. Price, Jeffrey R. Janus, J.K. Kasperbauer, Thomas H. Nagel, David M. Routman, Scott C. Lester, J.C. Rwigema, Ashish V. Chintakuntlawar, P. Savvides, Joaquín J. García

Year
2023
Citations
16

Keywords

MedicineTransoral robotic surgeryCommon Terminology Criteria for Adverse EventsSurgeryAdverse effectClinical trialSingle CenterInternal medicine

Related papers

Browse all SURGICAL papers